What type of study is this?

This is a Systematic Review study.

What question did this study set out to answer?

To evaluate the efficacy and safety of GLP-1 receptor agonists following bariatric surgery.

February 23, 2026Open Access

View Full Paper

Efficacy and Safety of Glucagon‐Like Peptide‐1 Receptor Agonists Following Bariatric Surgery: A Systematic Review and Meta‐Analysis

ABAbdur Rafay BilalZiauddin University ABAbdur Rafay BilalZiauddin University MIMuhammad IbrahimZiauddin University

Key Points

To evaluate the efficacy and safety of GLP-1 receptor agonists following bariatric surgery.
Conducted a systematic review and meta-analysis of existing studies
Assessed changes in weight, BMI, HbA1c, and total cholesterol
Focused on patients who underwent bariatric surgery
GLP-1RAs significantly reduced weight in patients after surgery
Marked reductions in BMI and HbA1c levels observed
Total cholesterol levels decreased significantly

Abstract

GLP-1RAs significantly reduce weight, BMI, HbA1c, and total cholesterol in patients following bariatric surgery. These findings highlight the potential of GLP-1RA therapy post-bariatric surgery. Future research is warranted to assess the long-term effects of GLP-1RA on the post-operative metabolic profile.

Ask AI

Helpful

Bookmark

View Full Paper

Ask AI

Helpful

Bookmark

View Full Paper

Efficacy and Safety of Glucagon‐Like Peptide‐1 Receptor Agonists Following Bariatric Surgery: A Systematic Review and Meta‐Analysis

Key Points

Abstract

Cite This Study